logo
Impact Radar
  • Overview
  • Impact Performance
  • Compare this company
  • All sources
    • Sign UpLog In
    logo

    Jazz Pharmaceuticals | Sustainability & Chart

    IE00B4Q5ZN47

    Basic information on Jazz Pharmaceuticals

    Location: Ireland

    Industry: Health Services

    Website

    knob-globe
    48%

    Impact Score

    Description Jazz Pharmaceuticals

    Jazz Pharmaceuticals plc is a global biopharmaceutical company focused on developing, manufacturing, and commercializing innovative medicines in areas such as neuroscience, oncology, and sleep medicine.

    Jazz Pharmaceuticals Sustainability Performance

    Renewable Energy
    Greenhouse Gas Emissions
    Supply Chain
    Waste Recycling
    Sustainable [100]
    Almost sustainable [67-99]
    Moderate [34-66]
    Not sustainable [0-33]
    No data
    We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

    Compare Jazz Pharmaceuticals with ...

    Jazz Pharmaceuticals

    ?

    Impact Score

    knob-globe
    48%
    knob-globe
    0%
    Climate
    Society
    Gender

    Sources of sustainability performance

    MetricValueUnitYearPDF NamePDF Page
    CEO Pay Ratio
    CEO nameRenee D. Gala2025sec-def-14a-2025-remuneration-report.pdf65
    CEO-to-median-salary-ratio69Ratio2025sec-def-14a-2025-remuneration-report.pdf111
    Glass Ceiling
    Women in management46%20242024 Jazz Annual Report.pdf41
    Women in workforce55%20242024 Jazz Annual Report.pdf41
    Greenhouse Gas Emissions
    Scope 2 emissions, location based4 361tCO₂e20252025_Jazz_Pharmaceuticals_Data_and_Disclosures_Appendix_F.pdf17
    Number of employees2 900people20252025_Jazz_Pharmaceuticals_Data_and_Disclosures_Appendix_F.pdf3
    Scope 1 emissions4 758tCO₂e20252025_Jazz_Pharmaceuticals_Data_and_Disclosures_Appendix_F.pdf17
    Harassment and Discrimination at the Workplace
    Anti-discrimination policyYes2025Jazz-Code-of-Conduct_0.pdf19
    Incident notification mechanismYes2025Jazz-Code-of-Conduct_0.pdf35
    Confidentiality mechanismsYes2025Jazz-Code-of-Conduct_0.pdf36
    Retaliation safeguardsYes2025Jazz-Code-of-Conduct_0.pdf36
    Renewable Energy
    Total energy consumption27 335 422kWh20252025_Jazz_Pharmaceuticals_Data_and_Disclosures_Appendix_F.pdf3
    Total renewable energy consumption11 487 843kWh20252025_Jazz_Pharmaceuticals_Data_and_Disclosures_Appendix_F.pdf3
    Women on Board
    Women on executive board3people2025sec-def-14a-2025-remuneration-report.pdf60
    Supervisory board size12people2025sec-def-14a-2025-remuneration-report.pdf36
    Executive board size5people2025sec-def-14a-2025-remuneration-report.pdf60
    Women on supervisory board4people2025sec-def-14a-2025-remuneration-report.pdf36
    Women in Management
    Women in management46%20242024 Jazz Annual Report.pdf41
    Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

    Find more sustainable companies

    logo
    HomeFind Companies & ETFsLearn to investAcademyGlossaryOur Method
    ImprintPrivacy PolicyGTCFAQContact Us
    © 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!Logos provided by Logo.dev